|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02561 VISEN PHARMA-B
Nominal 
40.020 +0.020 (+0.050%) | 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Turnover | 0 | -- | 0 | 0 |
| Cost of Sales | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- |
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | |
| Other Non-operating Items | (17,365) | 6.665% | (16,280) | (14,301) | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | |
| Profit / (Loss) before Taxation | (182,242) | -26.978% | (249,570) | (288,967) | |
| Taxation | 0 | -- | 0 | 0 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | |
| Others | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (182,242) | -26.978% | (249,570) | (288,967) | |
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (6,609) | -38.964% | (10,828) | (4,948) |
| Depreciation & Amortisation | 4,466 | -36.164% | 6,996 | 7,397 |
| Directors' Emoluments | 29,766 | 56.096% | 19,069 | 62,474 |
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified |
Market Valuation Indicators
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | |
| EPS (cts) | -- | -- | -- | -- |
| DPS (cts) | -- | -- | -- | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- |
| NBV per share ($) | -- | -- | -- | -- |
| Remarks: | Real time quote last updated: 28/10/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -118,020 |
| %Change | 41.390% |
| EPS / (LPS) | RMB -1.180 |
| NBV Per Share (¥) | RMB 7.510 |